semaglutide research labs GLP-1 SM – True Lab Peptides Semaglutide Analog GLP-1SG Research Peptide

Xenobiotica 45 (10), 921929

Phase 3 TRIUMPH-4 Results: The Latest Data (December 2025) The first Phase 3 results for Retatrutide came from the TRIUMPH-4 trial, announced by Eli Lilly on December 11, 2025

Therefore, the acute slope included data only for the European patients for whom these timepoints were evaluated

This study tracked cellular ageing and found that those treated with semaglutide (compared with placebo) showed slower biological aging across inflammation, brain and heart ageing measures

I just didnt want more food

The primary outcome of this study was reported in changes in neurocognitive performance measured by the Global Deficit Score (GDS) after 6 and 12 months